174
Participants
Start Date
February 15, 2007
Primary Completion Date
April 11, 2012
Study Completion Date
December 31, 2012
Erlotinib
"150 mg/day Patients will receive treatment until disease progression or unacceptable toxicity.~For all practical effects a treatment cycle will be defined as three weeks of continuous treatment with erlotinib"
Carboplatin
"Gemcitabine 1000 mg/m2 days 1 and 8 and Carboplatin AUC = 5 day 1, every 21 days.~Docetaxel (75 mg/m2) /carboplatin (AUC=6); Gemcitabine (1000 mg/m2; day 1 and 8) / Carboplatin (AUC=5)~Patients in the chemotherapy arm will receive the treatment until disease progression or unacceptable toxicity occurs, or until a maximum of 4 treatment cycles are given."
Gemcitabin
Cisplatin (75 mg/m2) / Gemcitabine (1250 mg/m2; day 1 and 8) Patients in the chemotherapy arm will receive the treatment until disease progression or unacceptable toxicity occurs, or until a maximum of 4 treatment cycles are given.
Docetaxel
Cisplatin (75 mg/m2) / Docetaxel (75 mg/m2) Patients in the chemotherapy arm will receive the treatment until disease progression or unacceptable toxicity occurs, or until a maximum of 4 treatment cycles are given.
Cisplatin
Cisplatin (75 mg/m2) / Docetaxel (75 mg/m2) Patients in the chemotherapy arm will receive the treatment until disease progression or unacceptable toxicity occurs, or until a maximum of 4 treatment cycles are given.
H. Provincial de Castellón, Castellon
Centre François Baclesse, Caen
H. Reina Sofía, Córdoba
Complejo Hosp. Univ. Juan Canalejo, A Coruña
ICO Girona -H. Dr. Josep Trueta, Girona
H. Virgen de las Nieves, Granada
H. de Donostia, Donostia / San Sebastian
Complejo Hospitalario de Jaén, Jaén
H. Arnau de Vilanova, Lleida
H. de la Princesa, Madrid
H. Gregorio Marañón, Madrid
H. Ruber Internacional, Madrid
H.U. Puerta de Hierro, Madrid
Fundación Jimenez Diaz, Madrid
Hospial Clinico San Carlos, Madrid
H. La Paz, Madrid
F.H.Alcorcón, Alcorcón
H. Fuenlabrada, Fuenlabrada
H. Carlos Haya, Málaga
H.C.Universitario Virgen de la Victoria, Málaga
Hôpital Auguste Morvan, Brest
Hôpital Larrey, Toulouse
CRO di Aviano, Aviano
Hospital Insular Gran Canaria, Las Palmas de Gran Canaria
CHU Rennes Hôpital Ponchaillou, Rennes
H. Ntra. Sra. de la Candelaria, Santa Cruz de Tenerife
H. Marqués de Valdecilla, Santander
H. Virgen del Rocío, Seville
H. Nuestra Sra. de Valme, Seville
H.C.U.Valencia, Valencia
H. General U. de Valencia, Valencia
H. Arnau de Vilanova Valencia, Valencia
H. Dr. Peset, Valencia
Hospital de Cruces, Barakaldo
H. Miguel Servet, Zaragoza
Centre Oscar Lambret, Lille
H. Clínico Lozano Blesa, Zaragoza
Hôpital Saint Antoine, Paris
AO Monaldi, Napoli
Hôpital du Cluzeau, Limoges
AO Materdomini, Catanzaro
"Casa di Cura La Maddalena", Palermo
Centre Hospitalier Intercommunal, Créteil
AOU Policlinico G. Martino, Messina
Centre Hospitalier Universitaire D'Angers, Angers
Centre Hospitalier René Dubos, Cergy-Pontoise
Hôpital A. Mignot, Le Chesnay
Centre Hospitalier Du Mans, Le Mans
Centre Hospitalier Régional, Longjumeau
Centre Hospitalier de Meaux, Meaux
Centre Hospitalier de Mulhouse, Mulhouse
Centre Hospitalier, Périgueux
Centre Hospitalier de La Région D'Annecy, Pringy
Centre Hosiptalier Genéral de Roanne, Roanne
Institut de Cancérologie de La Loire, Saint-Priest-en-Jarez
ICO - H. Germans Trias i Pujol, Badalona
H.G.U. Alicante, Alicante
Hospital San Millan Y San Pedro, Logroño
H. 12 de Octubre, Madrid
H. Ramon y Cajal, Madrid
Clinica Rotger, Palma de Mallorca
Istituti Fisioterapici Ospitalieri, Roma
AO S.Camillo Forlanini, Roma
"Università di Roma La Sapienza Az.Policlinico Umb.I°", Roma
PO di SS.ma Annunziata, Sassari
H. Virgen de los Lirios, Alcoy
H. Torrevieja Salud, Torrevieja
Hospital de Mataró, Mataró
H. Son Dureta, Palma de Mallorca
H. Santa Creu i Sant Pau, Barcelona
Instituto Universitario Dexeus, Barcelona
H.U.Vall D´Hebrón, Barcelona
H. Clinic i Provincial, Barcelona
H. Althaia, Barcelona
H. Duran i Reynals-ICO, Barcelona
H. Son Llàtzer, Palma de Mallorca
Spanish Lung Cancer Group
OTHER